Alicia Rodriguez‐Gabin

No ORCID on file · 1 paper in corpus · active 2014

Study types

  • article 1
article 2014
Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer
·doi:10.1016/j.ygyno.2014.03.334